Tilman Brandstetter

Title: Tilman Brandstetter: Innovator in Anti-Proliferative Compounds

Introduction

Tilman Brandstetter is a notable inventor based in Munich, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with anti-proliferative activity. His work is crucial in the fight against diseases such as cancer.

Latest Patents

Tilman Brandstetter holds a patent for "Derivatives of squaric acid with anti-proliferative activity." This invention provides derivatives of squaric acid, specifically derivatives of 3,4-diamino-cyclobut-3-ene-1,2-dione and its tautomers and isomers. These compounds can exist as a single stereoisomer or a mixture of stereoisomers, or as a pharmaceutically acceptable salt. The compounds demonstrate anti-proliferative activity, particularly against tumor cells, making them valuable in treating various diseases, including cancer. He has 1 patent to his name.

Career Highlights

Tilman Brandstetter is associated with Forma Tm, LLC, where he continues to innovate in the pharmaceutical sector. His work focuses on developing new therapeutic agents that can significantly impact patient care and treatment outcomes.

Collaborations

He collaborates with esteemed colleagues such as Krishna K Murthi and Roland Köstler, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Tilman Brandstetter's contributions to the field of anti-proliferative compounds highlight his role as a key inventor in the pharmaceutical industry. His work not only advances scientific knowledge but also holds the potential to improve treatment options for patients battling cancer and other diseases.